395
Views
3
CrossRef citations to date
0
Altmetric
Short Communications

Flow-mediated K+ secretion in horses intoxicated with lolitrem B (perennial ryegrass staggers)

&
Pages 159-164 | Received 23 Aug 2011, Accepted 15 Sep 2012, Published online: 08 Nov 2012
 

Abstract

AIM: To investigate the effects of lolitrem B intoxication on renal K+ secretion in response to increased tubular flow rates.

METHODS: Results are derived from a repeated measure pilot study of seven horses fed non-perennial ryegrass feed for a week prior to exposing them to perennial ryegrass seed and hay that contained an average of 2 ppm lolitrem B. At the end of the control and treatment period frusemide (1 mg/kg I/V) was administered and serial fractional excretion of K+(FEK+) and fractional excretion of Na+(FENa+) calculated. Baseline concentration of aldosterone in plasma, serum K+concentration and feed K+ concentration were also compared.

RESULTS: Key findings included a reduced change in FEK+ from 0 to 15 minutes in response to frusemide administration (p=0.022, Wilcoxon signed-rank test) and a reduced baseline concentration of aldosterone in plasma (p=0.022, Wilcoxon signed-rank test) during the treatment period compared with the control.

CONCLUSIONS: Results suggest that lolitrem B intoxication reduced flow-mediated K+ secretion and interfered with aldosterone production or secretion. However, further investigation is required to validate these findings and to further elucidate the underlying pathophysiology.

CLINICAL RELEVANCE: Lolitrem B intoxication in horses may cause disruption to electrolyte handling in addition to neurological deficits.

Acknowledgements

The authors would like to thank Louise and Andrew Scott for the use of their facilities and assistance during the trial and to thank Lester Fletcher for his advice and support. Funding for the research was provided by the New Zealand Equine Trust.

Notes

*Non-peer-reviewed

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.